case: relapsed/refractory waldenström macroglobulinemia
Published 5 years ago • 81 plays • Length 2:25Download video MP4
Download video MP3
Similar videos
-
2:39
case 4: relapsed-refractory myeloma
-
4:05
selecting therapy for relapsed-refractory dlbcl
-
33:10
dr. sheeba thomas relapsed refractory treatments
-
2:41
treatment options for relapsed-refractory dlbcl
-
3:31
nccn guidelines for relapsed/refractory mcl
-
4:52
therapy for relapsed or refractory mcl
-
4:59
case 3: molecular testing in relapsed myeloma
-
0:48
car t cell options for relapsed/refractory dlbcl
-
2:54
selecting therapy for relapsed-refractory dlbcl
-
6:43
current treatment approach to relapsed/refractory dlbcl
-
1:19
a study of duvelisib vs ofatumumab in relapsed/refractory cll
-
4:32
how is relapsed/refractory dlbcl treated?
-
1:06
gilteritinib monotherapy shows potential for treatment of relapsed/refractory flt3 aml
-
0:49
dr. davies on personalizing treatment in relapsed/refractory myeloma
-
2:32
using mrd status to guide treatment for relapsed/refractory multiple myeloma
-
1:04
navigating treatment options for patients with relapsed/refractory cll
-
0:56
ongoing studies for patients with relapsed/refractory aml
-
2:59
management of relapse/refractory multiple myeloma